Chloride deregulation and GABA depolarization in MTOR related malformations of cortical development.

GABAa receptor WNK1/SPAK-OSR1 epilepsy mTOR malformation of cortical dysplasia rapamycin

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 11 03 2024
revised: 15 06 2024
accepted: 19 07 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: aheadofprint

Résumé

Focal Cortical Dysplasia, Hemimegalencephaly and Cortical Tuber are pediatric epileptogenic malformations of cortical development (MCDs) frequently pharmaco-resistant and mostly surgically treated by the resection of epileptic cortex. Availability of cortical resection samples allowed significant mechanistic discoveries directly from human material. Causal brain somatic or germline mutations in the AKT/PI3K/DEPDC5/MTOR genes were identified. GABAa mediated paradoxical depolarization, related to altered chloride (Cl-) homeostasis, was shown to participate to ictogenesis in human pediatric MCDs. However, the link between genomic alterations and neuronal hyperexcitability is still unclear. Here we studied the post translational interactions between the mTOR pathway and the regulation of cation-chloride cotransporters (CCC), KCC2 and NKCC1, that are largely responsible for controlling intracellular Cl- and ultimately GABAergic transmission. For this study, 35 children (25 MTORopathies and 10 pseudo controls, diagnosed by histology plus genetic profiling) were operated for drug resistant epilepsy. Postoperative cortical tissues were recorded on multielectrode array (MEA) to map epileptic activities. CCC expression level and phosphorylation status of the WNK1/SPAK-OSR1 pathway was measured during basal conditions and after pharmacological modulation. Direct interactions between mTOR and WNK1 pathway components were investigated by immunoprecipitation. Membranous incorporation of MCD samples in Xenopus laevis oocytes enabled Cl- conductance and equilibrium potential (EGABA) for GABA measurement. Of the 25 clinical cases, half harbored a somatic mutation in the mTOR pathway, while pS6 expression was increased in all MCD samples. Spontaneous interictal discharges were recorded in 65% of the slices. CCC expression was altered in MCDs, with a reduced KCC2/NKCC1 ratio and decreased KCC2 membranous expression. CCC expression was regulated by the WNK1/SPAK-OSR1 kinases through direct phosphorylation of Thr906 on KCC2, that was reversed by WNK1 and SPAK antagonists (NEM and Staurosporine). mSIN1 subunit of MTORC2 was found to interact with SPAK-OSR1 and WNK1. Interactions between these key epileptogenic pathways could be reversed by the mTOR specific antagonist Rapamycin, leading to a dephosphorylation of CCCs and recovery of the KCC2/NKCC1 ratio. The functional effect of such recovery was validated by the restoration of the depolarizing shift in EGABA by rapamycin, measured after incorporation of MCD membranes to X. laevis oocytes, in line with a reestablishment of normal ECl-. Our study deciphers a protein interaction network through a phosphorylation cascade between MTOR and WNK1/SPAK-OSR1 leading to chloride cotransporters deregulation, increased neuronal chloride levels and GABAa dysfunction in malformations of Cortical Development, linking genomic defects and functional effects and paving the way to target epilepsy therapy.

Identifiants

pubmed: 39106285
pii: 7728044
doi: 10.1093/brain/awae262
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.

Auteurs

Naziha Bakouh (N)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.

Reyes Castaño-Martín (R)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.

Alice Metais (A)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, 75014 Paris, France.
GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, service de Neuropathologie, F-75014 Paris, France.

Emanuela Loredana Dan (EL)

STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, Romania.

Estelle Balducci (E)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Cerina Chhuon (C)

INSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.

Joanna Lepicka (J)

INSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.

Giulia Barcia (G)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.
Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Emma Losito (E)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Stéphane Lourdel (S)

Cordeliers Research Center, INSERM, Sorbonne University, Paris Cité University, 75006 Paris, France.
CNRS EMR 8228 - Laboratory of Renal Physiology and Tubulopathies, Paris, France.

Gabrielle Planelles (G)

Cordeliers Research Center, INSERM, Sorbonne University, Paris Cité University, 75006 Paris, France.
CNRS EMR 8228 - Laboratory of Renal Physiology and Tubulopathies, Paris, France.

Raul C Muresan (RC)

STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, Romania.

Vasile Vlad Moca (VV)

STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, Romania.

Anna Kaminska (A)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Marie Bourgeois (M)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Nicole Chemaly (N)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Yasmine Rguez (Y)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, 75014 Paris, France.

Stéphane Auvin (S)

Hôpital Robert Debré, Assistance Publique Hôpitaux de Paris, 75019 Paris, France.

Gilles Huberfeld (G)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, 75014 Paris, France.

Pascale Varlet (P)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, 75014 Paris, France.
GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, service de Neuropathologie, F-75014 Paris, France.

Vahid Asnafi (V)

Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Ida Chiara Guerrera (IC)

INSERM US24, Proteomic platform, SFR Necker, 75015 Paris, France.

Edor Kabashi (E)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.

Rima Nabbout (R)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.
Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Sorana Ciura (S)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.

Thomas Blauwblomme (T)

Université Paris Cité, INSERM U1163, Institut Imagine, « Translational Research in Neuroscience » Lab, 75015 Paris, France.
Department of Pediatric Neurosurgery Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.
Department of Pediatric Neurology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, 75015 Paris, France.

Classifications MeSH